The power of gamma delta T cells
Gamma delta T cells represent a new generation of immune cell therapy
The promise of our technology
Allogeneic
Novel Targeting
Available on Demand​
Adicet is developing allogeneic off-the-shelf genetically modified gamma delta T cells that selectively target tumors.
Recent News
March 11,
2024
February 29,
2024
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)